2019-11-15T16:15:16-06:00 2018-12-31 841158905 CAUSEY DEMGEN & MOORE PC 1099 18TH ST SUITE 2300 DENVER CO 80202 990 2018-01-01 200499338 INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER INTE 7203252948 13100 E COLFAX AVE NO 10 AURORA CO 80011 JOHN SKADOW CFO 7203252948 2019-11-15 1 JAMEY CAMP-CAVANAUGH P01382513 3032962229 38.140.32.146 2019-11-15 12:51:03 MS P A943A1BE274F0592E323C7ABAFE789F2B40FDF65 DF6922D84879EA8A33512D818366FE9773A0382B 2018 2020-03-31 21:24:44Z JOHN SKADOW 13100 E COLFAX AVE SUITE 10 AURORA CO 80011 14517639 0 X WWW.IASLC.ORG X 2003 CO TO PROMOTE THE STUDY OF THE ETIOLOGY, EPIDEMIOLOGY, PREVENTION, DIAGNOSIS, TREATMENT AND ALL OTHER ASPECTS OF LUNG CANCER AND OTHER THORACIC MALIGNANCIES.TO PROVIDE EDUCATION AND INFORMATION ABOUT LUNG CANCER AND OTHER THORACIC MALIGNANCIES TO IASLC MEMBERS, TO THE MEDICAL COMMUNITY AT LARGE, AND TO THE PUBLIC.TO USE ALL AVAILABLE MEANS TO ELIMINATE LUNG CANCER AND OTHER THORACIC MALIGNANCIES AS A HEALTH THREAT FOR THE INDIVIDUAL PATIENT AND THROUGHOUT THE WORLD. 20 20 25 0 0 0 959772 763425 13375777 13551881 325865 -303133 21252 10271 14682666 14022444 665000 128195 0 0 1974185 2659631 0 0 32888 12189218 11704519 14828403 14492345 -145737 -469901 19434955 18593846 5035650 4275893 14399305 14317953 X TO PROMOTE THE STUDY OF THE ETIOLOGY, EPIDEMIOLOGY, PREVENTION, DIAGNOSIS, TREATMENT AND ALL OTHER ASPECTS OF LUNG CANCER AND OTHER THORACIC MALIGNANCIES.TO PROVIDE EDUCATION AND INFORMATION ABOUT LUNG CANCER AND OTHER THORACIC MALIGNANCIES TO IASLC MEMBERS, TO THE MEDICAL COMMUNITY AT LARGE, AND TO THE PUBLIC.TO USE ALL AVAILABLE MEANS TO ELIMINATE LUNG CANCER AND OTHER THORACIC MALIGNANCIES AS A HEALTH THREAT FOR THE INDIVIDUAL PATIENT AND THROUGHOUT THE WORLD. 0 0 1843874 128195 96000 FELLOWSHIP, MEMBERSHIPS, AND OTHER PROGRAMS TO ADVANCE THE STUDY OF LUNG CANCER 1084615 1748414 PUBLICATIONS-PROVIDE EDUCATION TO THE WORLD WIDE LUNG CANCER COMMUNITY REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT. 9450954 6066766 MEETING AND WEB SEMINARS TO DISSEMINATE INFORMATION REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT. 12379443 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 1 0 0 1 1 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 60 0 1 25 1 0 0 0 0 0 0 0 0 0 0 X 20 20 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 1 1 0 CO X JOHN SKADOW CFO 7203252948 13100 E COLFAX AVE SUITE 10 AURORA CO 80111 TONY MOK MD TREASURER 10.00 X X 0 0 0 GIORGIO SCAGLIOTTI MD PHD PRESIDENT 10.00 X 0 0 0 TETSUYA MITSUDOMI MD PHD PRESIDENT ELECT 10.00 X 0 0 0 MICHAEL BOYER MD DIRECTOR 3.00 X 0 0 0 JULIE BRAHMER MD DIRECTOR 3.00 X 0 0 0 DAVID HARPOLE MD DIRECTOR 3.00 X 0 0 0 NORIHIKO IKEDA MD PHD DIRECTOR 3.00 X 0 0 0 ENRIQUETA FELIP PHD DIRECTOR 3.00 X 0 0 0 SURESH RAMALINGAM MD DIRECTOR 3.00 X 0 0 0 ANNE FRASER MD DIRECTOR 3.00 X 0 0 0 PAUL E VAN SCHIL MD PHD DIRECTOR 3.00 X 0 0 0 ROBERT PIRKER MD DIRECTOR 3.00 X 0 0 0 MARTIN RECK MD PHD DIRECTOR 3.00 X 0 0 0 MIYAKO SATOUCHI MD PHD DIRECTOR 3.00 X 0 0 0 TAKASHI SETO MD DIRECTOR 3.00 X 0 0 0 HEATHER WAKELEE MD DIRECTOR 3.00 X 0 0 0 JAMES YANG MD PHD DIRECTOR 3.00 X 0 0 0 MASAYUKI NOGUCHI MD DIRECTOR 3.00 X 0 0 0 CLARISSA MATHIAS MD DIRECTOR 3.00 X 0 0 0 DAVID MESKO CEO 40.00 X 0 205000 21475 PIA HIRSCH DIRECTOR OF EDUCATION 40.00 X 0 102963 11406 JOHN SKADOW DIRECTOR OF FINANCE 40.00 X 0 120100 16063 MURRY WYNES DIRECTOR OF SCIENTIFIC AFF 40.00 X 0 138212 14840 FRED HIRSCH MD PHD FORMER CEO/SECRETARY 30.00 X 0 317864 26923 0 884139 90707 0 1 1 0 INTERNATIONAL CONFERENCE SERVICES 1201 W PENDER ST STE 300 VANCOUVER BC CA V6E 2V2 CONFERENCE MANAGEMENT SERVICES 634662 FAIRMONT HOTEL 101 WILSHIRE BLVD SANTA MONICA CA 90401 CONFERENCE HOTEL 497714 CANCER RESEARCH & BIOSTATISTICS 1505 WESTLAKE AVENUE N STE 750 SEATTLE WA 98109 STATISTICIANS FOR PROJECTS 371792 ELSEVIER PO BOX 9546 NEW YORK NY 100874546 PRINTING SERVICES 357039 UNIVERSITY PHYSICIANS INC PO BOX 110247 AURORA CO 800420247 REIMBURSEMENT OF EXPENSES 355592 5 763425 763425 MEETING INCOME 541900 11492467 6066766 5425701 PUBLICATIONS 541900 1963414 1748414 215000 WEB SEMINARS 541900 96000 96000 0 13551881 192062 192062 10271 0 10271 10271 10271 495195 -495195 -495195 -495195 14022444 7911180 0 5347839 12322 12322 115873 115873 522864 522864 2136767 1515894 620873 37039 37039 32000 32000 60985 60985 228541 94847 133694 243798 165302 63720 14776 202998 137639 53056 12303 154002 107004 46998 8323347 7998022 325325 104790 73929 25052 5809 22996 22996 PUBLICATIONS 727670 727670 COMMITTEES 557406 557406 INTERNATIONAL PROGRAMS 370084 324687 45397 WEB SEMINARS 178408 178408 460455 370440 90015 14492345 12379443 2080014 32888 10460425 7925540 3917 1009 794626 0 877687 3183809 21842 0 1058918 1011290 1253525 589490 558124 664035 5659416 5808163 19434955 18593846 1181481 554584 3504439 3359311 349730 361998 5035650 4275893 X 14399305 14317953 14399305 14317953 19434955 18593846 X -469901 388550 -1 X X 0 1 X 1 0 X 1064804 784563 1047714 1251701 763425 4912207 4105370 13879388 13911465 13083848 13551881 58531952 5170174 14663951 14959179 14335549 14315306 63444159 0 0 0 63444159 148179 151809 202124 347114 -292863 556363 148179 151809 202124 347114 -292863 556363 5318353 14815760 15161303 14682663 14022443 64000522 0.99130 0.98410 0.00870 0.01590 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 408126 143485 264641 436950 321942 115008 408449 124063 284386 664035 ALTERNATIVE INVESTMENTS 326459 F OTHER SECURITIES 5481704 F 5808163 X PART X, LINE 2: THE ASSOCIATION HAS ADOPTED GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. AFTER EVALUATING THE TAX POSITIONS TAKEN, NONE ARE CONSIDERED TO BE UNCERTAIN; THEREFORE, NO AMOUNTS HAVE BEEN RECOGNIZED AS OF DECEMBER 31, 2018 AND 2017. THE ASSOCICATION IS NO LONGER SUBJECT TO U.S. FEDERAL INCOME TAX EXAMINATIONS FOR YEARS PRIOR TO 2015. 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES SCIENTIFIC CONFERENCE 21686 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES SCIENTIFIC CONFERENCE 59768 NORTH AMERICA 0 0 PROGRAM SERVICES SCIENTIFIC CONFERENCE 6036989 SOUTH AMERICA 0 0 PROGRAM SERVICES SCIENTIFIC CONFERENCE 220464 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES SCIENTIFIC CONFERENCE 225660 0 0 0 0 0 0 6564567 0 6564567 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. 115873 WIRE CASH THE IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. EAST ASIA AND THE PACIFIC 10 15485 THE IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. EUROPE (INCLUDING ICELAND & GREENLAND) 8 14750 THE IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. SOUTH ASIA 3 6208 THE IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. SOUTH AMERICA 2 3335 THE IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. EAST ASIA AND THE PACIFIC 20 61109 THE IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. EUROPE (INCLUDING ICELAND & GREENLAND) 10 14986 0 0 0 0 0 0 PART I, LINE 2: 1. GRANTS WILL BE INITIALLY REVIEWED BY THE COMMITTEE CHAIR FOR COMPLETENESS. INCOMPLETE SUBMISSIONS OR GRANTS SUBMITTED AFTER THE DEADLINE WILL BE RETURNED TO THE PI IN 48 HOURS. 2. EACH MEMBER OF THE SCIENTIFIC REVIEW COMMITTEE WILL RIGOROUSLY REVIEW THE APPLICATIONS. APPLICATIONS WILL BE SCORED ON FOUR CRITERIA: A. POTENTIAL OF THE CANDIDATE: IS THE CANDIDATE COMMITTED TO A CAREER IN LUNG CANCER RESEARCH? DOES THE CANDIDATE HAVE BASIC TRAINING RELATED TO THE PROJECT PROPOSED? PUBLISHED/SUBMITTED PAPERS OR ABSTRACTS CURRENT OR PENDING GRANT SUBMISSIONS STRONG LETTERS OF SUPPORT B. SCIENTIFIC MERIT OF THE PROJECT: IS THE PROPOSAL ORIGINAL? IS THE PROPOSAL CLEAR & CONCISE? ARE THE SPECIFIC AIMS REASONABLE? IS THE METHODOLOGY REASONABLE TO ACCOMPLISH THE OBJECTIVES? CAN THE PROJECT BY COMPLETED IN THE 2 YEAR TIME FRAME? C. SIGNIFICANCE OF PROJECT: IS THE PROJECT WITHIN THE IASLC SCOPE? WHAT WILL THIS INFORMATION CONTRIBUTE TO KNOWLEDGE IN THIS FIELD? DO THESE RESULTS SIGNIFICANTLY IMPROVE THE APPLICATION OF KNOWLEDGE OF LUNG CANCER? WILL THESE DATA STIMULATE FURTHER SCIENTIFIC RESEARCH INTO LUNG CANCER? D. STRENGTH OF THE PI/INSTITUTIONAL SUPPORT (FOR FELLOWSHIP GRANTS): IS THE PI DEDICATED TO ASSISTING IN THE EXECUTION AND COMPLETION OF THE PROJECT? IS THE PI OF GOOD STANDING IN THE FIELD OF LUNG CANCER RESEARCH? DOES THE PI HAVE SUFFICIENT GRANT SUPPORT FOR THE FELLOW TO COMPLETE THE PROJECT IF REQUIRED? DOES THE INSTITUTION HAVE THE NECESSARY RESOURCES TO SUPPORT THE PROJECT? SCORES WILL RANGE FROM 1-5. 5 - OUTSTANDING 4 - EXCELLENT 3 - GOOD 2 - POOR 1 - UNACCEPTABLE TOTAL SCORES WILL THEN BE TABULATED, AVERAGED, AND THE CANDIDATE RANKED. THE COMMITTEE WILL MEET BY CONFERENCE CALL TO SELECT THE AWARDEES. 3. PROGRESS REPORTS FROM YEAR 1 WILL BE REVIEWED BY THE COMMITTEE CHAIR. PART I, LINE 3: BUDGET REVIEW AND APPROVAL WAS REQUIRED FOR EACH CONFERENCE. 1 IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. 7 12322 1 X X 0 0 0 0 0 0 0 0 0 DAVID MESKO CEO 0 205000 0 0 0 0 0 0 0 21475 0 226475 0 0 MURRY WYNES DIRECTOR OF SCIENTIFIC AFF 0 138212 0 0 0 0 0 0 0 14840 0 153052 0 0 FRED HIRSCH MD PHD FORMER CEO/SECRETARY 0 317864 0 0 0 0 0 0 0 26923 0 344787 0 0 FORM 990, PART VI, SECTION A, LINE 2 PIA HIRSCH, DIRECTOR OF EDUCATION AND FRED HIRSCH, FORMER CEO, MD, PHD, ARE SPOUSES. FORM 990, PART VI, SECTION B, LINE 11B FOR 2018, THE CEO & CFO WILL REVIEW THE RETURN PRIOR TO THE FILING OF FORM 990. THE TAX RETURN WILL BE AVAILABLE TO THE BOARD AND FINANCE COMMITTEE FOR REVIEW FOLLOWING THE FILING OF FORM 990. FORM 990, PART VI, SECTION B, LINE 12C THROUGH YEARLY REVIEWS FORM 990, PART VI, SECTION B, LINE 15 THROUGH YEARLY REVIEWS FORM 990, PART VI, SECTION C, LINE 19 AVAILABLE UPON REQUEST FORM 990, PART XI, LINE 9: ROUNDING -1. PART XII, LINE 2C NO CHANGES TO PROCEDURES IN CURRENT YEAR